HB 1099·SD·house
reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Signed into LawFiled Jan 21, 2026
Sponsor: Pischke
Latest Action
Signed by the Governor
Mar 10, 2026
Track this bill
Get real-time alerts when HB 1099 changes status, plus AI-powered summaries and stage predictions.
Sign up free